Celularity Inc. Files 8-K/A Amendment
Ticker: CELUW · Form: 8-K/A · Filed: Jul 29, 2025 · CIK: 1752828
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Celularity filed an amendment to its 8-K, check for updated financials/exhibits.
AI Summary
Celularity Inc. filed an amendment (8-K/A) on July 29, 2025, to its report originally dated February 12, 2025. This amendment pertains to financial statements and exhibits, with the date of change also being February 12, 2025. The company, formerly GX Acquisition Corp., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be material for investors to review.
Risk Assessment
Risk Level: low — This is a routine amendment filing for financial statements and exhibits, not indicating new material events.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- GX Acquisition Corp. (company) — Former company name
- February 12, 2025 (date) — Date of earliest event reported
- July 29, 2025 (date) — Filing date of amendment
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the purpose of this 8-K/A filing?
This filing is an amendment (Amendment No. 1) to a previous 8-K report, specifically concerning financial statements and exhibits.
When was the original report filed or effective?
The earliest event reported was on February 12, 2025, and the filing date of the amendment is July 29, 2025.
What was Celularity Inc.'s former name?
Celularity Inc.'s former name was GX Acquisition Corp.
In which state is Celularity Inc. incorporated?
Celularity Inc. is incorporated in Delaware.
What is the primary business sector for Celularity Inc.?
Celularity Inc. is in the Pharmaceutical Preparations sector, SIC code 2834.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on July 29, 2025 regarding Celularity Inc (CELUW).